-transparent.png){kind=logo}
Serum growth hormone (GH) behaviour after levodopa administration was measured in twelve healthy subjects both in basal conditions and after a 4 day course of pimozide (4 mg daily), a specific blocker of dopamine (DA) receptors. In addition, fasting plasma GH was measured on the first, second and third day of treatment. No significant difference was found between GH response to levodopa in basal conditions and after pimozide; moreover, fasting GH was uninfluenced by pimozide.
Related Publications
A Masala, and
G Delitala, and
S Alagna, and
L Devilla
August 1975,
Endocrinologia japonica,
A Masala, and
G Delitala, and
S Alagna, and
L Devilla
April 1977,
The Journal of clinical endocrinology and metabolism,
A Masala, and
G Delitala, and
S Alagna, and
L Devilla
October 1975,
Acta endocrinologica,
A Masala, and
G Delitala, and
S Alagna, and
L Devilla
December 1975,
Military medicine,
A Masala, and
G Delitala, and
S Alagna, and
L Devilla
December 1984,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
A Masala, and
G Delitala, and
S Alagna, and
L Devilla
November 1990,
The Journal of clinical endocrinology and metabolism,
A Masala, and
G Delitala, and
S Alagna, and
L Devilla
April 1974,
The Journal of endocrinology,
A Masala, and
G Delitala, and
S Alagna, and
L Devilla
May 1975,
The Journal of clinical endocrinology and metabolism,
A Masala, and
G Delitala, and
S Alagna, and
L Devilla
January 1979,
The Journal of clinical endocrinology and metabolism,
A Masala, and
G Delitala, and
S Alagna, and
L Devilla
November 1979,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
